MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?

    M. Rossi, S. Perez-Lloret, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…
  • MDS Virtual Congress 2021

    Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)

    JM. Perez Imbernon, S. Lopez Calvo, F. Castillo Alvarez, MT. Marti Sanchez, MM. Zambrano Vera, N. Reurich Gomez, ME. Marzo Sola (Logroño, Spain)

    Objective: To present a Parkinson´s Disease (PD) patient who presented a rapidly progressive dementia after MR-FUS therapy. Background: MR-FUS thalamotomy is used for unilateral essential…
  • MDS Virtual Congress 2021

    Mild cognitive impairment does not predict development of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson’s disease

    SF. Fjeldhøj, BLC. Thomsen, PMP. Pedersen, SRJ. Jensen, MK. Karlsborg, AL. Løkkegaard (Copenhagen, Denmark)

    Objective: This is a long-term follow-up study of a group of patients with levo-dopa responsive fluctuating Parkinson’s disease (PD), with focus on the short- and…
  • MDS Virtual Congress 2021

    Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change

    X. Ren, J. Lin, G. Stebbins, C. Goetz, S. Luo (Foster City, CA, USA)

    Objective: To develop a prognostic model using multiple longitudinal measures to predict temporal clinical progression in early PD. Background: Predicting time to Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    The Commercial Genetic Testing Landscape for Parkinson’s Disease

    L. Cook, J. Schulze, J. Verbrugge, C. Klein, A. Naito, R. Alcalay (Indianapolis, USA)

    Objective: To evaluate commercial genetic testing offered for Parkinson’s disease (PD) Background: The etiology of PD is complex and, typically, multifactorial. At least 6 genes…
  • MDS Virtual Congress 2021

    Increased stroke risk in Parkinson’s disease patients with LRRK2 mutations

    D. Macias-Garcia, MT. Periñán, L. Muñoz-Delgado, S. Jesús, MV. Jimenez-Jaraba, D. Buiza-Rueda, M. Bonilla-Toribio, A. Adarmes-Gomez, F. Carrillo, P. Gómez-Garré, P. Mir (Seville, Spain)

    Objective: To determine whether genetic forms of Parkinson’s Disease (PD), such as LRRK2-mutated PD (LRRK2-PD) and GBA­-mutated PD (GBA­-PD), have a different vascular risk compared…
  • MDS Virtual Congress 2021

    Parkinson’s Families Project: analysis of a large cohort of patients with early onset and familial Parkinson’s disease

    C. Towns, M. Tan, M. Pollard, S. Cable, L. Wu, R. Real, H. Morris (London, United Kingdom)

    Objective: We aim to identify new gene variants associated with familial and early-onset Parkinson's disease (PD), through genetic comparison of affected and unaffected family members.…
  • MDS Virtual Congress 2021

    Effects of fine particulate matter and cigarette smoking on MPTP-induced dopaminergic neuronal cell death: Implication for Parkinson’s disease

    YJ. Jung, H. Choi, E. Oh (Seoul, Republic of Korea)

    Objective: The objective of this study was to determine the potential neurotoxicity of fine particulate matter (FPM) and the neuroprotective properties of nicotine in the pathogenesis…
  • MDS Virtual Congress 2021

    Functional connectivity as an early marker of indication for deep brain stimulation treatment in Parkinson’s disease (PD)

    L. Albano, F. Agosta, S. Basaia, C. Cividini, T. Stojkovic, E. Sarasso, I. Stankovic, A. Tomic, V. Markovic, E. Stefanova, P. Mortini, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To identify functional neuroimaging patterns anticipating the clinical indication for deep brain stimulation (DBS) in patients with PD. Background: DBS has become a well-established…
  • MDS Virtual Congress 2021

    A DIFFERENT RADIOLOGICAL PERSPECTIVE ON PARKINSON’S DISEASE AND PARKINSONISM: TRANSCRANIAL SONOGRAPHY

    S. Eroglu Durmaz, O. Kursun, N. Oztekin, Y. Sucullu Karadag (Ankara, Turkey)

    Objective: This study aims to investigate the reliability of Transcranial Sonography (TCS) in the diagnosis of Parkinson’s Disease (PD) and its contribution to the differential…
  • « Previous Page
  • 1
  • …
  • 415
  • 416
  • 417
  • 418
  • 419
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley